Merck & Co., Inc: Asthma trials
The registry lists 23 Asthma studies with Merck & Co., Inc as lead sponsor. 0 are open to participants now and 13 have results posted.
Phase 1 10Phase 2 12No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)CompletedNCT02720081Phase 2Results posted
- A Study to Evaluate the Effect of Gefapixant (AF-219/MK-7264) on Methacholine Hyper-reactivity in Participants With Asthma (MK-7264-009)CompletedNCT01993329Phase 2Results posted
- A Study to Evaluate the Safety and Use of Human Rhinovirus in Healthy and Asthmatic Participants (MK-0000-218)CompletedNCT01866306Phase 1Results posted
- A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)TerminatedNCT01656395Phase 2Results posted
- Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011)CompletedNCT01624974Phase 2Results posted
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate AsthmaCompletedNCT01370317Phase 1Results posted
- A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003)CompletedNCT01343407Phase 1Results posted
- A Study on the Effects of a Single Dose of Prednisone on Biomarkers of Allergen Responses in Asthmatics (MK-0000-175)CompletedNCT01193049Phase 1Results posted
- Early Airway Response to Allergen in Asthmatics (MK-0000-176)CompletedNCT01061333Phase 1Results posted
- Efficacy and Safety of Navarixin (SCH 527123) in Participants With Allergen-Induced Asthma (P05363)CompletedNCT00688467Phase 2Results posted
- Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED)CompletedNCT00632502Phase 2Results posted
- Induced Sputum Study (0000-065)CompletedNCT00623714Phase 1Results posted
- Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295)CompletedNCT00394914Phase 2Results posted
- Comparison of RPL554 With Placebo and Salbutamol in Asthmatic PatientsCompletedNCT02427165Phase 2
- A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003)WithdrawnNCT01926002Phase 1
- Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1)WithdrawnNCT01006161Phase 2
- MK0524 Asthma POC Study (0524-008)(COMPLETED)CompletedNCT00783601Phase 2
- MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028)CompletedNCT00768170Phase 1
- Plasma Levels of MK0633 in Children Ages 6-12 (0633-023)CompletedNCT00751413Phase 1
- A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019)CompletedNCT00646789Phase 1
- A Study of MK0359 in Patients With Chronic Asthma (0359-013)CompletedNCT00482898Phase 2
- The Effect of MK0633 in Patients With Chronic Asthma (0633-007)TerminatedNCT00404313Phase 2
- Instrument Utility for Suspected Asthma (0000-042)(COMPLETED)CompletedNCT00211575Not applicable